CNBC CanSino Biologics CEO on earnings, business outlook, and international partnerships Posted: April 30, 2025 | Last updated: April 30, 2025 Yu Xuefeng, CEO of Chinese vaccine company CanSino ...

Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, commented, "At WuXi Biologics, we believe that long-term business success is inseparable from our responsibility to people, ...

manufacturing and warehouse capabilities to enable the launch and commercial production of next-generation biologics and therapies including potent antibody-drug conjugates (ADCs), reinforcing ...

Haier Smart Home and WuXi Biologics all rose 0.22 percent, CNOOC improved 0.83 percent, CSPC Pharmaceutical surrendered 1.15 percent, Galaxy Entertainment retreated 1.06 percent, Hang Lung ...

Contributing to United Nations Sustainable Development Goals Enhancing transparency and effectiveness for corporate governance Empowering employees and delivering positive impact to communities ...

Unleashing the power of its unique CRDMO business model, technology strength and operational excellence, WuXi Biologics has successfully continued to execute its "Follow and Win the Molecule" ...

1 Day WXIBF 9.49% DJIA -0.29% S&P 500 -0.07% Health Care/Life Sciences 0.62% ...

Bengaluru-based Biocon Biologics Ltd (BBL), the biosimilars company and subsidiary of Biocon Ltd, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

Journalists take a ride on the self-driving bus in Wuxi Economic Development District on April 22. [Photo provided to chinadaily.com.cn] Wuxi, a city in East China's Jiangsu province, is emerging ...